Search research articles
Contact Us
Filters
Showing results (151-160 of 158) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 158 results.
The New England Journal of Medicine
|
February 25, 2026
Tecovirimat for the Treatment of Mpox
Jason Zucker, William A Fischer, Lu Zheng, et al.
Open Forum Infectious Diseases
|
June 13, 2024
Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City
Elizabeth A Garcia, Mary M K Foote, Tristan D McPherson, et al.
Plos One
|
April 8, 2021
What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
Monica Mehta, Lawrence J Purpura, Thomas H McConville, et al.
Neurology. Clinical Practice
|
November 16, 2022
Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19: A Case-Control Study in New York City
Kiran T Thakur, Victoria T Chu, Christine Hughes, et al.
Lancet (London, England)
|
February 24, 2023
Mpox in people with advanced HIV infection: a global case series
Oriol Mitjà, Andrea Alemany, Michael Marks, et al.
JAMA Network Open
|
April 23, 2021
Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic
Geoffrey A Rubin, Amar D Desai, Zilan Chai, et al.
Plos One
|
December 28, 2020
High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy
Jacob S Stevens, Kristen L King, Shelief Y Robbins-Juarez, et al.
The Lancet. HIV
|
August 7, 2025
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process
Chloe Orkin, Amy Paterson, Alexa Elias, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 158) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 158 results.
The New England Journal of Medicine
|
February 25, 2026
Tecovirimat for the Treatment of Mpox
Jason Zucker, William A Fischer, Lu Zheng, et al.
Open Forum Infectious Diseases
|
June 13, 2024
Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City
Elizabeth A Garcia, Mary M K Foote, Tristan D McPherson, et al.
Plos One
|
April 8, 2021
What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
Monica Mehta, Lawrence J Purpura, Thomas H McConville, et al.
Neurology. Clinical Practice
|
November 16, 2022
Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19: A Case-Control Study in New York City
Kiran T Thakur, Victoria T Chu, Christine Hughes, et al.
Lancet (London, England)
|
February 24, 2023
Mpox in people with advanced HIV infection: a global case series
Oriol Mitjà, Andrea Alemany, Michael Marks, et al.
JAMA Network Open
|
April 23, 2021
Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic
Geoffrey A Rubin, Amar D Desai, Zilan Chai, et al.
Plos One
|
December 28, 2020
High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy
Jacob S Stevens, Kristen L King, Shelief Y Robbins-Juarez, et al.
The Lancet. HIV
|
August 7, 2025
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process
Chloe Orkin, Amy Paterson, Alexa Elias, et al.
Page
of 16